NASDAQ:MLTX | Profit Breakdown | MoonLake Immunotherapeutics

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$61.66M-$61.81M
2026-03-31-$70.02M-$69.71M
2025-12-31-$65.22M-$62.43M
2025-09-30-$71.43M-$69.73M
2025-06-30-$60.7M-$55.22M
2025-03-31-$47.49M-$39.94M
2024-12-31-$49.58M-$45.61M
2024-09-30-$43.11M-$35.39M
2024-06-30-$30.58M-$24.27M
2024-03-31-$19.82M-$13.67M
2023-12-31-$15.03M-$7.44M
2023-09-30-$12.98M-$9.43M
2023-06-30-$13.19M-$10.14M
2023-03-31-$12.93M-$9M
2022-12-31-$16.7M-$17.11M
2022-09-30-$14.77M-$10.11M
2022-06-30-$17.65M-$12.12M
2022-03-31-$15.94M-$15.88M
2021-12-31$34.73M$34.78M
2021-09-30-$6.27M-$6.29M
2021-06-30-$32.68M-$32.69M
2021-03-31-$94,106.00-$76,291.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$244.83M-$229.71M-$227.32M
2024-12-31-$143.09M-$120.96M-$118.94M
2023-12-31-$54.12M-$43.99M-$36.01M
2022-12-31-$65.06M-$64.47M-$49.97M
2021-12-31-$4.57M-$4.54M